Top Markets
Coin of the day
Immunotech Laboratories, Inc. Immunotech Laboratories, Inc.

Immunotech Laboratories, Inc.

IMMB
Classement en actions #40594
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins... Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Enzolytics, Inc.
Prix de l'action
$0.0002
Dernière synchronisation: 2026-08-12
Capitalisation boursière
$114.99K
Changement (1 jour)
0.00%
Changement (1 an)
100.00%
Pays
US
Échange Immunotech Laboratories, Inc. (IMMB)

Catégorie

Historique du rendement du dividende pour Immunotech Laboratories, Inc. (IMMB)
Le rendement du dividende (TTM) de Immunotech Laboratories, Inc. (symbole boursier : IMMB) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Immunotech Laboratories, Inc. (IMMB) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
Entreprise Rendement du dividende Pays
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
0.65%
BE